Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix

International Journal of Cancer

Volumn 121, Issue 12, 2007, Pages 2674-2681

  Khouadri, Soraya ^a   Villa, Luisa L ^b   Gagnon, Simon ^a   Koushik, Anita ^c   Richardson, Harriet ^c   Matlashewski, Greg ^c   Roger, Michel ^a   Ferenczy, Alex S ^c   Franco, Eduardo L ^c   Coutlée, François ^a,c,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c MCGILL UNIVERSITY   (Canada)

^d NOTRE DAME HOSPITAL   (Canada)

Author keywords

Cervical cancer; HPV; HSIL; Integration; Viral load

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 33; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; VIRUS LOAD;

ADULT; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOPATHOGENIC EFFECT, VIRAL; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PLASMIDS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VIRAL ENVELOPE PROTEINS; VIRAL LOAD;

EID: 36248977576     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23006     Document Type: Article

References (41)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
2. Ferenczy A, Franco EL. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002;3:11-16.
3. Fontaine J, Hankins C, Mayrand MH, Lefevre J, Money D, Gagnon S, Rachlis A, Pourreaux K, Ferenczy A, Coutlee F. High levels of episomal and integrated HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS 2005;19:785-94.
4. Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 2003;103:519-24.
5. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PKE, Anderson PK, Ponten J, Adami HO, Gyllensten UB, Melbye M. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2194-8.
6. Moberg M, Gustavsson I, Wilander E, Gyllensten U. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 2005;92:891-4.
7. Wang SS, Hildesheim A. Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 2003;35-40.
8. Cheung JL, Lo KW, Cheung TH, Tang JW, Chan PK. Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. J Infect Dis 2006;194:1706-12.
9. Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, Luthra R, Zhang W. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 2007;20:256-66.
10. Hopman AHN, Smedts F, Dignef W, Ummulen M, Sonke G, Mravunac M, Vooijs GP, Speel EJM, Ramaekers FCS. Transition to high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol 2004;202:23-33.
11. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 2006;44:1755-62.
12. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, Lotz B, Melsheimer P, Doeberitz MV. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999;59:6132-6.
13. kulmala S-MA, Syrjanen SM, Gyllensten UB, Shabalova IP, Petrovichev N, Tosi PT, Syrjanen KJ, Johansson BC. Early integration of high copy HPV-16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 2007;59:513-17.
14. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40:886-91.
15. Gallo G, Bibbo M, Bagella L, Zamparelli A, Sanseverino F, Giovagnoli MR, Vecchione A, Giordano A. Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol 2003;56:532-6.
16. Dias D, Van-Doren J, Schlottmann S, Kelly S, Puchalski D, Ruiz W, Boerckel P, Kessler J, Antonello JM, Green T, Brown M, Smith J, et al. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16 and 18. Clin Diagn Lab Immunol 2005;12:959-69.
17. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur HH. Classification of papillomaviruses. Virology 2004;324:17-27.
18. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006;24:S26-S34
19. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:101-5.
20. Fontaine J, Gravitt P, Duh LM, Lefevre J, Pourreaux K, Hankins C, Coutlee F. High level of correlation of human papillomavirus-16 DNA viral load estimates generated by three real-time PCR assays applied on genital specimens. Cancer Epidemiol Biomarkers Prev 2005;14:2200-7.
21. Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Feirreira S, Tellier P, Matlashewski G, Roger M, Franco ELF, Coutlée F. Human papillomavirus type 33 polymorphism and high-grade lesions of the uterine cervix. J Infect Dis 2006;194:886-94.
22. Koushik A, Ghosh A, Duarte-Franco E, Forest P, Voyer H, Matlashewski G, Coutlee F, Franco EL. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detect Prev 2005;29:307-16.
23. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-114.
24. Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Coutlée F, Franco E. The natural history of type-specific HPV infections in female university students. Cancer Epidemiol Biomarkers Prev 2003;12:485-90.
25. Tran-Thanh D, Provencher D, Koushik A, Duarte-Franco E, Kessous-Elbaz A, Drouin P, Wheeler C, Dubuc-Lissoir J, Gauthier P, Allaire G, Vauclair R, DiPaolo J et al. Herpes Simplex Virus Type II (HSV-2) is not a Cofactor to Human Papillomavirus in Cancer of the Uterine Cervix. Am J Obstet Gynecol 2003;188:129-34.
26. Cole ST, Streek RE. Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J Virol 1986;58:991-5.
27. Lefevre J, Hankins C, Pourreaux K, Voyer H, The Canadian Women's HIV study Group, Coutlée F. Real-time PCR assays using internal Controls for quantitation of HPV-16 and β-globin DNA in cervicovaginal lavages. J Virol Methods 2003;144:135-44.
28. Lefevre J, Hankins C, Pourreaux K, The Canadian Women's HIV study Group, Coutlée F. Prevalence of selective inhibition of HPV-16 DNA amplification in cervicovaginal lavages. J Med Virol 2004;132-7.
29. Fink L, Seeger W, Ermert L, Hanze J, Stahl U, Grimminger F, Kummer W, Bohle RM. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998;4:1329-33.
30. Reidy PM, Dedo HH, Rabah R, Field JB, Mathog RH, Gregoire L, Lancaster WD. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 2004;114:1906-9.
31. Thorland EC, Myers SL, Persing DH, Sarkar G, McGovem RM, Gostout BS, Smith DI. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res 2000;60:5916-21.
32. Bleeker MC, Hogewoning CJ, Berkhof J, Voorhorst FJ, Hesselink AT, van-Diemen PM, van-den-Brule AJ, Snijders PJ, Meijer CJ. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005;41:612-20.
33. Moberg M, Gustavsson I, Gyllensten U. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer 2004;112:854-9.
34. Snidjers PJF, Hogewoning CJ, Hesselink AT, Berkhof J, Voohorst FJ, Bleeker MC, Meijer CJLM. Determination of viral load thresholds in cervical scrapes to rule out CIN3 in HPV 16, 18, 31 and 33-positive women with normal cytology. Int J Cancer 2006;119:1102-7.
35. Weissenborn SJ, Funke AM, Hellmich M, Mallmann P, Fuschs PG, Pfister HJ, Wieland U. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with High-grade cervical lesions are strongly elevated. J Clin Microbiol 2003;41:2763-7.
36. Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, Hoeckel M, von-Knebel-Doeberitz M. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 2003;22:3977-84.
37. Kalantari M, Karlsen F, Kristensen G, Holm R, Hagmar B, Johansson B. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 1998;17:146-153.
38. Wagatsuma M, Hashimoto K, Matsukura T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J Virol 1990;64:813-21.
39. Giannoudis A, van Duin M, Snijders PJF, Herrington CS. Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix. Br J Cancer 2001;84:1058-63.
40. De Marco L, Gillio-Tos A, Bonello L, Ghisetti V, Ronco G, Merletti F. Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. J Clin Virol 2007;38:7-13.
41. Rajeevan MS, Swan DC, Nisenbaum R, Lee DR, Vernon SD, Ruffin MT, Horowitz IR, Flowers LC, Kmak D, Tadros T, Birdsong G, Husain M, et al. Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer 2005;115:114-120.